Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bavarian Nordic ADR (BVNRY)

Bavarian Nordic ADR (BVNRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,675,202
  • Shares Outstanding, K 234,294
  • Annual Sales, $ 1,025 M
  • Annual Income, $ 214,090 K
  • 60-Month Beta 1.50
  • Price/Sales 1.63
  • Price/Cash Flow 201.10
  • Price/Book 1.19
Trade BVNRY with:
  • Price/Earnings ttm 5.47
  • Earnings Per Share ttm 1.30
  • Most Recent Earnings $0.56 on 03/06/24
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.25
  • Growth Rate Est. (year over year) +399,500.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.9200 +3.32%
on 04/18/24
7.8450 -8.86%
on 04/03/24
-0.4000 (-5.30%)
since 03/22/24
3-Month
6.9200 +3.32%
on 04/18/24
8.6050 -16.91%
on 02/26/24
-0.5700 (-7.38%)
since 01/23/24
52-Week
5.9511 +20.15%
on 10/30/23
10.6500 -32.86%
on 06/13/23
-2.1800 (-23.37%)
since 04/21/23

Most Recent Stories

More News
These 3 Companies Are Taking on Monkeypox

A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.

BVNRY : 7.1500 (+0.56%)
PFE : 26.27 (-0.19%)
SIGA : 8.66 (-1.14%)
DGX : 137.55 (+0.62%)
LH : 207.94 (-0.01%)
Here's Why Bavarian Nordic (BVNRY) is a Great Momentum Stock to Buy

Does Bavarian Nordic (BVNRY) have what it takes to be a top stock pick for momentum investors? Let's find out.

BVNRY : 7.1500 (+0.56%)
Bavarian Nordic (BVNRY) is on the Move, Here's Why the Trend Could be Sustainable

Bavarian Nordic (BVNRY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through...

BVNRY : 7.1500 (+0.56%)
Bavarian Nordic (BVNRY)'s Technical Outlook is Bright After Key Golden Cross

Is it a good or bad thing when a stock experiences a golden cross technical event?

BVNRY : 7.1500 (+0.56%)
Bavarian Nordic (BVNRY) Soars 7.1%: Is Further Upside Left in the Stock?

Bavarian Nordic (BVNRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....

BVNRY : 7.1500 (+0.56%)
CDAK : 0.0570 (-55.98%)
What Monkeypox Could Mean for These 2 Stocks?

Vaccine companies saw stock prices spike during the COVID pandemic. The same could happen amid a new outbreak.

PFE : 26.27 (-0.19%)
BVNRY : 7.1500 (+0.56%)
SIGA : 8.66 (-1.14%)
Are These 4 Stocks Smart Buys With the Monkeypox Outbreak?

The monkeypox opportunity could already be baked into the prices of these stocks.

BVNRY : 7.1500 (+0.56%)
SIGA : 8.66 (-1.14%)
CMRX : 0.9060 (-2.09%)
EBS : 2.18 (-4.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical...

See More

Key Turning Points

3rd Resistance Point 7.1500
2nd Resistance Point 7.1500
1st Resistance Point 7.1500
Last Price 7.1500
1st Support Level 7.1500
2nd Support Level 7.1500
3rd Support Level 7.1500

See More

52-Week High 10.6500
Fibonacci 61.8% 8.8550
Fibonacci 50% 8.3005
Fibonacci 38.2% 7.7461
Last Price 7.1500
52-Week Low 5.9511

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar